Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer. | Prostate Cancer Prostatic Dis;4(1): 44-55, 2001. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.

Nasu, Y; Bangma, C H; Hull, G W; Yang, G; Wang, J; Shimura, S; McCurdy, M A; Ebara, S; Lee, H-M; Timme, T L; Thompson, T C.

Affiliation

Nasu Y; Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.

Prostate Cancer Prostatic Dis ; 4(1): 44-55, 2001.

Article in En | MEDLINE | ID: mdl-12497062

Search on Google

Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2001 Document type: Article Affiliation country: Country of publication: